(1) Construction of new basic research laboratories for cancer research; (2) construction of new clinical and support facilities for cancer research; (3) construction of facilities for cancer research related to biohazard control; (4) upgrading of existing basic research and animal facilities for cancer research; and (5) upgrading of existing clinical and support facilities for cancer research.
The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
|Recipient||Amount||Start Date||End Date|
|University Of Washington||$ 2,143,337||   ||2009-07-17||2013-06-30|
|St Jude Children`s Research Hospital||$ 932,984||   ||2002-01-01||2010-12-31|
|University Of Oklahoma Health Sciences Center||$ 219,750||   ||2008-04-01||2010-03-31|
|Panorama Research, Inc||$ 190,350||   ||2007-08-09||2008-07-31|
|Molecular Express, Inc||$ 248,564||   ||2007-05-04||2008-04-30|
|Ctrc Research Foundation||$ 900,000||   ||2006-07-01||2006-09-30|
|Ctrc Research Foundation||$ 870,000||   ||2006-07-01||2006-09-30|
|University Of Wisconsin System/board Of R||$ 3,000,000||   ||2003-09-15||2005-08-31|
|H Lee Moffitt Cancer Center & Research In||$ 1,500,000||   ||2002-09-15||2004-09-30|
|Ctrc Research Foundation||$ 1,770,000||   ||2000-10-01||2004-07-31|
No awards were made in fiscal years 2007 and 2008. The NCI's construction grant program is not a very active program compared to the past because the National Center for Research Resources has become the effective focus at the NIH for construction grants; thus, the NCI works very closely with NCRR.
Uses and Use Restrictions
New physical resources for cancer research include basic research laboratories, clinical and support facilities, and those related to biohazard control that are integral parts of an overall effort.
Proposed facilities must be part of an existing cancer research effort or a developing cancer research program.
Facilities constructed may not be used to replace existing cancer research facilities.
Facilities shall be used for research pertinent to cancer problems for as long as needed, usually 20 years.
Funds must be used for purposes stated in the approved grant application.
Any public or nonprofit agency, institution, organization, corporation, or association is eligible to apply for a grant for the construction of cancer research facilities, provided the institution's (1) Located in a State, the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, American Samoa, the Trust Territory of the Pacific Islands, or Guam; (2) authorized by its governing body to apply for grants and to conduct cancer research and related activities; and (3) conducting NIH or NCI peer-reviewed cancer and/or cancer-related research.
Examples include universities, colleges, hospitals, public agencies or nonprofit research institutions.
Public and private nonprofit organizations and the public needing treatment for cancer will benefit.
Application should include a complete research program description (with staff curricula vitae), space requirements for projected program, an environmental summary of the impact of the proposed facility as detailed in Public Law 90-190, the National Environmental Policy Act, and listing of all relevant licenses, permits, or other approvals required by State and local authorities. Costs will be determined in accordance with OMB Circular No. A-21 for Educational Institutions, OMB Circular No. A-87 for State and local governments, and OMB Circular No. A-122 for nonprofit institutions. For grants issued to hospitals, costs will be determined in accordance with HHS Regulations 45 CFR Part 74, Appendixes E, "Principles for Determining Costs Applicable to Research and Development Under Grants and Contracts with Hospitals".
Aplication and Award Process
Preapplication assistance is available from the address noted below under Information Contacts.
The standard application forms (PHS 5161-1), as furnished by PHS and required by 45 CFR 92 for State and local governments, must be used for this program.
An environmental impact statement and assessment is required for this program.
This program is eligible for coverage under E.O.
12372, "Intergovernmental Review of Federal Programs".
An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review.
Application kits for construction programs can be obtained from Research Facilities Branch, Office of Centers, Training and Resources, Office of the Director, National Cancer Institute, 6120 Executive Boulevard, EPS-638, Bethesda, MD 20892, and returned to the Center for Scientific Review, National Institutes of Health, Bethesda, MD 20892. Review procedure is according to NIH grant review procedures for research grants.
Awards are made annually following the meeting of the National Cancer Advisory Board in September/October.
Public Health Service Act, Section 413(b) 6(B); 42 U.S.C 285a and Section 414(b); 42 U.S.C 285, as amended; Public Law 100-607; Public Law 101-517; Public Law 90-190.
Range of Approval/Disapproval Time
From 8 to 16 months.
A principal investigator may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH home page www.nih.gov/grants/guide/1997/97.11.21/n2.html.
Formula and Matching Requirements
This program has no statutory formula. The National Cancer Institute (NCI) will award up to 50 percent of the eligible costs. Matching funds from nonfederal sources are required.
Length and Time Phasing of Assistance
Construction must be completed within time specified in grant award. Funds will be released in proportion to construction completed.
Post Assistance Requirements
Grantee is responsible for performance of contractor.
Contractor must be covered by performance and payment bonds.
Grantees are required to file a Notice of Federal Interest at the time construction begins.
In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Nonprofit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials.
Expenditures and other financial records must be retained for 3 years from the day on which the grantee submits the last financial status report for the report period.
(Grants) FY 07 $0; FY 08 est $0; and FY 09 est $0.
Range and Average of Financial Assistance
$0 to $0; $0.
Regulations, Guidelines, and Literature
45 CFR 38; PHS Grants Policy Statement, DHHS Publication No. (OASH) 90-50,000, (Rev.) October 1, 1990.
Regional or Local Office
Program Contact: Mr. Daryl Paunil, P.E., Associate Director, (Acting) for Space and Facilities Planning, Office of Management, Office of the Director, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, 6116 Executive Boulevard, Suite 600 - MSC 8343, Bethesda, MD 20892-8343. Telephone: (301) 496-8534. Grants Management Contact: Leo F. Buscher, Jr., Grants Management Officer, National Cancer Institute, EPS-234 Bethesda, MD 20892. Telephone: (301) 496-7753. Use the same numbers for FTS.
Criteria for Selecting Proposals
The major elements in evaluating proposals include assessments of: (1) the scientific merit of the total cancer program; (2) the degree of the applicant's program relevance to the National Cancer Program; (3) the special biohazard containment needs; and (4) the evaluation of the ongoing program for research pertinent to cancer problems for at least 20 years; and (5) the evaluation of the proposed design and related cost.